Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 158

The DOI matches its Crossref record.

Postoperative External Beam Radiotherapy for Differentiated Thyroid Cancer: Outcomes and Morbidity With Conformal Treatment

Open access
Schwartz, David L., Lobo, Mark J., Ang, K. Kian, Morrison, William H., Rosenthal, David I., Ahamad, Anesa, Evans, Douglas B., Clayman, Gary, Sherman, Steven I., Garden, Adam S. · 2009 · International Journal of Radiation Oncology*Biology*Physics

Abstract

Purpose To review institutional outcomes for patients treated for differentiated thyroid cancer with post-operative conformal external beam radiotherapy (EBRT). Methods This is a single institution retrospective review of one hundred thirty-one consecutive patients with differentiated thyroid cancer who underwent EBRT between 1/1996 and 12/2005. Histologic diagnoses included 104 papillary, 21 follicular, and 6 mixed papillary-follicular. AJCC stage distribution was 2 stage III, 128 stage IVa–c, and not accessible in 1. Thirty-four (26%) patients had high-risk histology and 76 (58%) had recurrent disease. Extraglandular disease spread was seen in 126 (96%) cases, microscopically positive surgical margins in 62 (47%) and gross residual disease in 15 (11%). Median EBRT dose was 60 Gy [range: 38–72 Gy]. Fifty-seven (44%) patients were treated with IMRT to a median dose of 60 Gy [range: 56–66 Gy]. Median follow-up was 38 months (range: 0–134). Results Kaplan-Meier estimates of locoregional relapse free survival (LRFS), disease specific survival (DSS), and overall survival (OS) at 4 years were 79%, 76%, and 73%, respectively. On multivariate analysis, high-risk histologic features and gross residual disease predicted for inferior LRFS, while high-risk histologic features, M1 disease, and gross residual disease predicted for inferior DSS and OS. IMRT did not impact survival outcomes, but was associated with less frequent severe late morbidity (12% vs.2%). Conclusions Post-operative conformal EBRT provides durable locoregional disease control for high-risk differentiated thyroid cancer if disease is reduced to microscopic burden. Patients with gross disease face significantly worse outcomes. IMRT may significantly reduce chronic radiation morbidity, but requires further study.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ijrobp.2008.09.023

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 158

Metadata

Authors
Schwartz, D. L., Lobo, M. J., Ang, K. K., Morrison, W. H., Rosenthal, D. I., Ahamad, A., Evans, D. B., Clayman, G., Sherman, S. I., & Garden, A. S.
Venue
International Journal of Radiation Oncology*Biology*Physics
Publisher
Elsevier BV
Published
2009-07
Volume
74
Issue
4
Pages
1083-1091
ISSN
0360-3016 (ISSN-L)
OpenAlex
W2051686109
Cited by
158
References
0
FWCI
3.92
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Postoperative External Beam Radiotherapy for Differentiated Thyroid Cancer: Outcomes and Morbidity With Conformal Treatment. https://app.cochat.ai/papers/10.1016/j.ijrobp.2008.09.023
The paper
Schwartz, D. L., Lobo, M. J., Ang, K. K., Morrison, W. H., Rosenthal, D. I., Ahamad, A., Evans, D. B., Clayman, G., Sherman, S. I., & Garden, A. S. (2009). Postoperative External Beam Radiotherapy for Differentiated Thyroid Cancer: Outcomes and Morbidity With Conformal Treatment. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2008.09.023

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.